Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. McGibbon A, Adams L, Ingersoll K, et al. Glycemic management in adults with type 1 diabetes. Can J Diabetes. 2018;42(Suppl 1):S80–7.
2. Lipscombe L, Butalia S, Dasgupta K, et al. Pharmacologic glycemic management of type 2 diabetes in adults: 2020 update. Can J Diabetes. 2020;44(7):575–91.
3. Rosenstock J, Juneja R, Beals JM, et al. The basis for weekly insulin therapy: evolving evidence with insulin icodec and insulin efsitora alfa. Endocr Rev. 2024;45(3):379–413.
4. Shetty S, Suvarna R. Efficacy and safety of once-weekly insulin icodec in type 2 diabetes: a meta-analysis of ONWARDS phase 3 randomized controlled trials. Diabetes Obes Metab. 2024;26(3):1069–81.
5. Novo Nordisk A/S. Awiqli (insulin icodec) 700 units/mL solution for injection in pre-filled pen: EU summary of product characteristics. 2024. https://www.ema.europa.eu/en/documents/product-information/awiqli-epar-product-information_en.pdf. Accessed 20 June 2024.